Ryokichi Irisawa
Overview
Explore the profile of Ryokichi Irisawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A case of peripheral T-cell lymphoma NOS presenting as a subcutaneous tumor with favorable prognosis
Mae K, Irisawa R, Wakimoto H, Harada K, Hamada T
J Dermatol
. 2025 Feb;
PMID: 39891481
No abstract available.
2.
Ito T, Kukino R, Sarayama Y, Tanioka M, Maekawa T, Yatsushiro H, et al.
J Dermatol
. 2024 Dec;
52(2):e49-e69.
PMID: 39723550
"Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition" is revised from the first edition, which was published in the...
3.
Hayakawa K, Irisawa R, Umefune R, Mae K, Shimada Y, Takahashi R, et al.
J Dermatol
. 2024 Apr;
51(9):e306-e307.
PMID: 38605458
No abstract available.
4.
Numata T, Irisawa R, Mori M, Uchiyama M, Harada K
Acta Derm Venereol
. 2024 Jan;
104:adv18348.
PMID: 38248913
No abstract available.
5.
Ishimatsu-Tsuji Y, Niiyama S, Irisawa R, Harada K, Kishimoto J, Tsuboi R
J Dermatol Sci
. 2023 Nov;
113(1):26-33.
PMID: 38016881
Background: Autologous cell-based therapy using dermal sheath cup (DSC) cells was reported as a new treatment for male and female pattern hair loss. However, the mechanisms underlying its action remain...
6.
Harada K, Ohyama M, Niiyama S, Irisawa R, Mae K, Mori M, et al.
J Dermatol
. 2023 Sep;
50(12):1539-1549.
PMID: 37752738
A previous, proof-of-concept clinical study suggested that dermal sheath cup cell injections into the affected areas of male/female pattern hair loss (PHL) may have some amelioratory effects, the clinical efficacy...
7.
Takase K, Itonaga T, Mikami R, Irisawa R, Saito K
Cureus
. 2022 Jun;
14(5):e25056.
PMID: 35719801
The aim of this study was to demonstrate the utility of the dose-volume parameters of the target lesions and the radiation dose to the organ at risk (OAR) in two...
8.
Kato Y, Fukuhara Y, Nagatani T, Kanzaki A, Mae K, Irisawa R, et al.
Dermatology
. 2022 May;
238(5):961-966.
PMID: 35551376
Background/aim: MST-16 and VP-16, both of which are topoisomerase II inhibitors, are antitumor agents regularly used to treat malignant lymphoma and small cell lung carcinoma. New therapeutic agents for tumor...
9.
Irisawa R, Tsuboi R, Saito M, Harada K
J Dermatol
. 2021 Jan;
48(4):476-480.
PMID: 33460189
Intra-anal warts are frequently recalcitrant to surgical removal, but imiquimod 5% cream is not formulated to use in clinical practice due to the risk of mucosal inflammation. In the present,...
10.
Mae K, Tsuboi R, Irisawa R, Sato T, Fukushima N, Harada K
J Dermatol
. 2021 Jan;
48(5):661-666.
PMID: 33404107
The present, retrospective, single-center study analyzed various factors associated with primary basal cell carcinoma (BCC) in the period before and after the introduction of dermoscopy (BD and AD, respectively). The...